Reaction
Catheter Site Irritation reporting signals
As of the last recalculation, Catheter Site Irritation appears in 315 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 876.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 112 | 876.7 | 884.3 |
| Macitentan | 101 | 141.4 | 141.6 |
| Sildenafil | 76 | 113.9 | 114.1 |
| Treprostinil | 108 | 86.0 | 86.1 |
| Tadalafil | 78 | 68.1 | 68.1 |
| Sildenafil Citrate | 93 | 68.1 | 68.1 |
| Riociguat | 25 | 54.9 | 55.0 |
| Selexipag | 16 | 43.1 | 43.1 |
| Sildenafil Powder, | 21 | 41.7 | 41.7 |
| Ambrisentan | 49 | 30.5 | 30.5 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 30.2 | 30.3 |
| Rasagiline Mesylate | 5 | 30.1 | 30.2 |